These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34568427)

  • 41. Aurora-A modulates MMP-2 expression via AKT/NF-κB pathway in esophageal squamous cell carcinoma cells.
    Wang X; Li X; Li C; He C; Ren B; Deng Q; Gao W; Wang B
    Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):520-7. PubMed ID: 27125974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide analysis of long non-coding RNAs in esophageal squamous cell carcinoma reveals their potential role in invasion and metastasis.
    Wang J; Sun D; Wu K; Liu J; Zhao M; Li X; Xu Y; Li B
    Thorac Cancer; 2019 Jan; 10(1):78-89. PubMed ID: 30390388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spatially resolved metabolomics to discover tumor-associated metabolic alterations.
    Sun C; Li T; Song X; Huang L; Zang Q; Xu J; Bi N; Jiao G; Hao Y; Chen Y; Zhang R; Luo Z; Li X; Wang L; Wang Z; Song Y; He J; Abliz Z
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):52-57. PubMed ID: 30559182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
    Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
    Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
    Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
    Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional characterization of a low-frequency V1937I variant in FASN associated with susceptibility to esophageal squamous cell carcinoma.
    Wang X; Tian J; Zhao Q; Yang N; Ying P; Peng X; Zou D; Zhu Y; Zhong R; Gao Y; Chang J; Miao X
    Arch Toxicol; 2020 Jun; 94(6):2039-2046. PubMed ID: 32388819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.
    Jin Z; Xu L; Zhang L; Zhao M; Li D; Ye L; Ma Y; Ren S; Yu H; Wang D; Liang C; Chen B
    Am J Transl Res; 2018; 10(6):1677-1689. PubMed ID: 30018709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic analysis of interleukin enhancer binding factor 3 (Ilf3) and nuclear factor 90 (NF90) interactome.
    Chaumet A; Castella S; Gasmi L; Fradin A; Clodic G; Bolbach G; Poulhe R; Denoulet P; Larcher JC
    Biochimie; 2013 Jun; 95(6):1146-57. PubMed ID: 23321469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of FBP1 promotes proliferation, migration, and invasion by regulating fatty acid metabolism in esophageal squamous cell carcinoma.
    He Y; Hua R; Li B; Gu H; Sun Y; Li Z
    Aging (Albany NY); 2020 Nov; 13(4):4986-4998. PubMed ID: 33232284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway.
    Pu Z; Wu L; Guo Y; Li G; Xiang M; Liu L; Zhan H; Zhou X; Tan H
    J Cell Biochem; 2019 Oct; 120(10):18172-18185. PubMed ID: 31144362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SENP2 promotes ESCC proliferation through SETDB1 deSUMOylation and enhanced fatty acid metabolism.
    Sun L; Ma K; Zhang S; Gu J; Wang H; Tan L
    Heliyon; 2024 Jul; 10(13):e34010. PubMed ID: 39071660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
    Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
    Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.